Skip to main content
Figure 1 | Journal of Translational Medicine

Figure 1

From: Abnormal T regulatory cells (Tregs: FOXP3+, CTLA-4+), myeloid-derived suppressor cells (MDSCs: monocytic, granulocytic) and polarised T helper cell profiles (Th1, Th2, Th17) in women with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC) and surgery: failure of abolition of abnormal treg profile with treatment and correlation of treg levels with pathological response to NAC

Figure 1

(A) Correlation between % of regulatory FOXP3+(CD4+CD25+CD127-FOX P3+) T cells before and after NAC and subsequent histological response in the breast following NAC (n = 16), graded as complete (cPR, 5), very good (VG, 4), partial (3), poor and no pathological response (2 + 1) in the breast following NAC. Values shown are means ± standard deviations. Statistical analysis: Spearman’s correlation coefficient Rho = −0.620, p = 0.04 (2-tailed) (pre-chemotherapy) and Rho = −0.799, p = 0.05 (2-tailed) (post-chemotherapy) (B) Correlation between % of regulatory CTLA-4+ (CD4+ CD25+ CD152+) T cells before and after NAC and subsequent histological response in the breast following NAC (n = 16), graded as complete (cPR, 5), very good (VG, 4), partial (3), poor and no pathological response (2 + 1) in the breast following NAC. Values shown are means ± standard deviations. Statistical analysis: Spearman’s correlation coefficient Rho = 0.260, p = 0.78 (NS) (pre-chemotherapy) and Rho = −0.794, p = 0.01 (2-tailed) (post-chemotherapy).

Back to article page